NYSE - Delayed Quote USD

Evolent Health, Inc. (EVH)

8.83
+0.01
+(0.11%)
At close: May 16 at 4:00:02 PM EDT
8.83
0.00
(0.00%)
After hours: May 16 at 5:44:12 PM EDT
Loading Chart for EVH
  • Previous Close 8.82
  • Open 8.81
  • Bid 8.80 x 800
  • Ask 8.80 x 900
  • Day's Range 8.53 - 8.85
  • 52 Week Range 8.35 - 33.63
  • Volume 1,799,841
  • Avg. Volume 2,706,033
  • Market Cap (intraday) 1.037B
  • Beta (5Y Monthly) 1.04
  • PE Ratio (TTM) --
  • EPS (TTM) -1.23
  • Earnings Date Aug 6, 2025 - Aug 11, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 15.31

Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated platform for health plan administration and value-based business infrastructure. It also provides administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management; and Machinify Auth, a software platform that leverages advances in artificial intelligence. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.

www.evolent.com

4,500

Full Time Employees

December 31

Fiscal Year Ends

Recent News: EVH

View More

Performance Overview: EVH

Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

EVH
21.51%
S&P 500 (^GSPC)
1.30%

1-Year Return

EVH
62.12%
S&P 500 (^GSPC)
12.48%

3-Year Return

EVH
69.28%
S&P 500 (^GSPC)
48.66%

5-Year Return

EVH
16.49%
S&P 500 (^GSPC)
108.07%

Compare To: EVH

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: EVH

View More

Valuation Measures

Annual
As of 5/15/2025
  • Market Cap

    1.04B

  • Enterprise Value

    1.66B

  • Trailing P/E

    --

  • Forward P/E

    22.62

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.42

  • Price/Book (mrq)

    1.11

  • Enterprise Value/Revenue

    0.69

  • Enterprise Value/EBITDA

    50.94

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -4.54%

  • Return on Assets (ttm)

    -0.04%

  • Return on Equity (ttm)

    -9.24%

  • Revenue (ttm)

    2.4B

  • Net Income Avi to Common (ttm)

    -140.48M

  • Diluted EPS (ttm)

    -1.23

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    246.55M

  • Total Debt/Equity (mrq)

    77.09%

  • Levered Free Cash Flow (ttm)

    2.23M

Research Analysis: EVH

View More

Company Insights: EVH

Research Reports: EVH

View More

People Also Watch